    <SEC-DOCUMENT>0001104659-23-022228-index.html : 20230215
    <SEC-HEADER>0001104659-23-022228.hdr.sgml : 20230215
    <ACCEPTANCE-DATETIME>20230215081939
    ACCESSION NUMBER:		0001104659-23-022228
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20220930
    FILED AS OF DATE:		20230215
    DATE AS OF CHANGE:		20230215
    EFFECTIVENESS DATE:		20230215

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001649989
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				383982704
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			0930

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37759
    		FILM NUMBER:		23633706

    	BUSINESS ADDRESS:
    		STREET 1:		485 ROUTE 1 SOUTH
    		STREET 2:		BUILDING F, SUITE 320
    		CITY:			ISELIN
    		STATE:			NJ
    		ZIP:			08830
    		BUSINESS PHONE:		6096193990

    	MAIL ADDRESS:
    		STREET 1:		485 ROUTE 1 SOUTH
    		STREET 2:		BUILDING F, SUITE 320
    		CITY:			ISELIN
    		STATE:			NJ
    		ZIP:			08830

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Oncobiologics, Inc.
    		DATE OF NAME CHANGE:	20150804
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>tm233336d2_ars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: tm233336d2_ars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>